|
We are continuing to expand our presence in Central and Eastern Europe to further meet the patient recruitment needs of our pharmaceutical customers. Our office in Bucharest, is currently involved in feasibility, regulatory and monitoring of Phase II and III clinical studies, and provides coverage to Moldova and Ukraine.
|
